• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[基于反向遗传学的口蹄疫疫苗研究进展]

[Advances in reverse genetics-based vaccines of foot and mouth disease].

作者信息

Yang Bo, Yang Fan, Wang Song-Hao, Zhang Yan, Cao Wei-Jun, Yin Hong, Zheng Hai-Xue

出版信息

Bing Du Xue Bao. 2014 Mar;30(2):213-20.

PMID:24923178
Abstract

Reverse-genetic engineering of foot and mouth disease virus (FMDV) can improve the productivity, antigen matching, antigen stability, immune response ability, and biological safety of vaccines, so vaccine candidates with anticipated biological characteristics can be promptly achieved. Negative influence in taming of virulent strains can also be decreased or avoided. Reverse genetics not only make up for deficiencies like limitation of viral nature, low success rate, and time and energy consuming, but also realize more active designing of vaccines. Therefore, reverse genetics is significant in improving integral quality and efficiency of vaccines. In this review, we use FMDV vaccines as an example to summarize improvement in biological characteristics of virulent strains and provide a reference for related researches.

摘要

口蹄疫病毒(FMDV)的反向遗传工程可提高疫苗的生产力、抗原匹配性、抗原稳定性、免疫应答能力和生物安全性,从而能够迅速获得具有预期生物学特性的候选疫苗。同时,还可减少或避免强毒株驯化过程中的负面影响。反向遗传学不仅弥补了诸如病毒特性限制、成功率低以及耗时耗力等不足,还实现了更为主动的疫苗设计。因此,反向遗传学对于提高疫苗的整体质量和效率具有重要意义。在本综述中,我们以FMDV疫苗为例,总结强毒株生物学特性的改进情况,为相关研究提供参考。

相似文献

1
[Advances in reverse genetics-based vaccines of foot and mouth disease].[基于反向遗传学的口蹄疫疫苗研究进展]
Bing Du Xue Bao. 2014 Mar;30(2):213-20.
2
[Evaluation of synthetic peptide vaccines against foot-and-mouth disease type A].[针对A型口蹄疫的合成肽疫苗评估]
Wei Sheng Wu Xue Bao. 2013 Jun 4;53(6):596-607.
3
Study of a chimeric foot-and-mouth disease virus DNA vaccine containing structural genes of serotype O in a genome backbone of serotype Asia 1 in guinea pigs.在豚鼠中对一种嵌合口蹄疫病毒DNA疫苗的研究,该疫苗在亚洲1型基因组骨架中包含O型结构基因。
Acta Virol. 2010;54(3):189-95. doi: 10.4149/av_2010_03_189.
4
Increased efficacy of an adenovirus-vectored foot-and-mouth disease capsid subunit vaccine expressing nonstructural protein 2B is associated with a specific T cell response.表达非结构蛋白 2B 的腺病毒载体口蹄疫衣壳亚单位疫苗的效力增加与特定的 T 细胞反应有关。
Vaccine. 2011 Nov 28;29(51):9431-40. doi: 10.1016/j.vaccine.2011.10.037. Epub 2011 Oct 24.
5
Efficacy of synthetic peptide candidate vaccines against serotype-A foot-and-mouth disease virus in cattle.合成肽候选疫苗对牛口蹄疫病毒血清型 A 的效力。
Appl Microbiol Biotechnol. 2015 Feb;99(3):1389-98. doi: 10.1007/s00253-014-6129-1. Epub 2014 Nov 9.
6
Orally delivered foot-and-mouth disease virus capsid protomer vaccine displayed on T4 bacteriophage surface: 100% protection from potency challenge in mice.展示于T4噬菌体表面的经口服递送的口蹄疫病毒衣壳原聚体疫苗:对小鼠效力挑战的100%保护率
Vaccine. 2008 Mar 10;26(11):1471-81. doi: 10.1016/j.vaccine.2007.12.053. Epub 2008 Jan 24.
7
Comparison of immune responses to different foot-and-mouth disease genetically engineered vaccines in guinea pigs.豚鼠对不同口蹄疫基因工程疫苗免疫反应的比较。
J Virol Methods. 2008 Jan;147(1):143-50. doi: 10.1016/j.jviromet.2007.08.027. Epub 2007 Oct 25.
8
Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.水疱性口炎病毒糖蛋白 G 携带口蹄疫病毒抗原位点 A 的串联二聚体可作为牛的 DNA 和肽疫苗使用。
Antiviral Res. 2011 Nov;92(2):219-27. doi: 10.1016/j.antiviral.2011.08.006. Epub 2011 Aug 26.
9
Development of novel strategies to control foot-and-mouth disease: marker vaccines and antivirals.控制口蹄疫新策略的研发:标记疫苗和抗病毒药物。
Biologicals. 2005 Dec;33(4):227-34. doi: 10.1016/j.biologicals.2005.08.009. Epub 2005 Nov 14.
10
Custom-engineered chimeric foot-and-mouth disease vaccine elicits protective immune responses in pigs.定制工程嵌合口蹄疫疫苗在猪中引发保护性免疫应答。
J Gen Virol. 2011 Apr;92(Pt 4):849-59. doi: 10.1099/vir.0.027151-0. Epub 2010 Dec 22.